The proposed transaction pertains to acquisition of 100 per cent of the equity shareholding of Parexel International, according to a notice filed with the regulator. “Commission approves acquisition of Parexel International Corporation by Phoenix Parentco, Inc,” the watchdog said in a tweet on Monday.
